Industry Research Reports
Home > Reports > Pharma & Healthcare > Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
NAD+ Intravenous Therapy Market Size(US$)
CAGR 2025-2031
7.5%
Market Size,2031
USD 479
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 311 million
Market Forecast in 2031(Value)
US$ 479 million
CAGR
7.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
NAD+ IV Therapy is a wellness therapy that involves the intravenous administration of nicotinamide adenine dinucleotide (NAD+), a coenzyme crucial for cellular energy production and metabolic processes. This therapy is believed to boost energy levels, enhance cognitive function, and promote overall cellular repair by increasing NAD+ levels, which naturally decline with age.
The North America NAD+ Intravenous Therapy market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of NAD+ Intravenous Therapy include The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global NAD+ Intravenous Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company
- The Wellness Lab
- Conciergemdla
- Azivmedics
- Reset IV
- Thedripclub
- Toronto Functional Medicine Centre
- Mobileivmedics
- Rocky Mountain Ivmedics
- Seaside Skin Care
- Premiumhealth
- Effect Doctors
- Nadclinic
- Hydrate IV Bar
- LIVV Natural
- BioReset Medical
- IV Boost UK
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Segment by Application
- Clinic
- Hospital
- Residential
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of NAD+ Intravenous Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Pure NAD+ Injection in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospital in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the NAD+ Intravenous Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 NAD+ Mixed Vitamin Injections
1.2.3 Pure NAD+ Injection
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Residential
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NAD+ Intravenous Therapy Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global NAD+ Intravenous Therapy Revenue Market Share by Region (2020-2025)
2.4 Global NAD+ Intravenous Therapy Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America NAD+ Intravenous Therapy Market Size and Prospective (2020-2031)
2.5.2 Europe NAD+ Intravenous Therapy Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific NAD+ Intravenous Therapy Market Size and Prospective (2020-2031)
2.5.4 Latin America NAD+ Intravenous Therapy Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa NAD+ Intravenous Therapy Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global NAD+ Intravenous Therapy Historic Market Size by Type (2020-2025)
3.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Type (2026-2031)
3.3 Different Types NAD+ Intravenous Therapy Representative Players
4 Breakdown Data by Application
4.1 Global NAD+ Intravenous Therapy Historic Market Size by Application (2020-2025)
4.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in NAD+ Intravenous Therapy Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top NAD+ Intravenous Therapy Players by Revenue (2020-2025)
5.1.2 Global NAD+ Intravenous Therapy Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by NAD+ Intravenous Therapy Revenue
5.4 Global NAD+ Intravenous Therapy Market Concentration Analysis
5.4.1 Global NAD+ Intravenous Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by NAD+ Intravenous Therapy Revenue in 2024
5.5 Global Key Players of NAD+ Intravenous Therapy Head office and Area Served
5.6 Global Key Players of NAD+ Intravenous Therapy, Product and Application
5.7 Global Key Players of NAD+ Intravenous Therapy, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America NAD+ Intravenous Therapy Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America NAD+ Intravenous Therapy Market Size by Type (2020-2025)
6.1.2.2 North America NAD+ Intravenous Therapy Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America NAD+ Intravenous Therapy Market Size by Application (2020-2025)
6.1.3.2 North America NAD+ Intravenous Therapy Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe NAD+ Intravenous Therapy Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe NAD+ Intravenous Therapy Market Size by Type (2020-2025)
6.2.2.2 Europe NAD+ Intravenous Therapy Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe NAD+ Intravenous Therapy Market Size by Application (2020-2025)
6.2.3.2 Europe NAD+ Intravenous Therapy Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific NAD+ Intravenous Therapy Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific NAD+ Intravenous Therapy Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific NAD+ Intravenous Therapy Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific NAD+ Intravenous Therapy Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific NAD+ Intravenous Therapy Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America NAD+ Intravenous Therapy Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America NAD+ Intravenous Therapy Market Size by Type (2020-2025)
6.4.2.2 Latin America NAD+ Intravenous Therapy Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America NAD+ Intravenous Therapy Market Size by Application (2020-2025)
6.4.3.2 Latin America NAD+ Intravenous Therapy Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa NAD+ Intravenous Therapy Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa NAD+ Intravenous Therapy Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa NAD+ Intravenous Therapy Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa NAD+ Intravenous Therapy Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa NAD+ Intravenous Therapy Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 The Wellness Lab
7.1.1 The Wellness Lab Company Details
7.1.2 The Wellness Lab Business Overview
7.1.3 The Wellness Lab NAD+ Intravenous Therapy Introduction
7.1.4 The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.1.5 The Wellness Lab Recent Development
7.2 Conciergemdla
7.2.1 Conciergemdla Company Details
7.2.2 Conciergemdla Business Overview
7.2.3 Conciergemdla NAD+ Intravenous Therapy Introduction
7.2.4 Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.2.5 Conciergemdla Recent Development
7.3 Azivmedics
7.3.1 Azivmedics Company Details
7.3.2 Azivmedics Business Overview
7.3.3 Azivmedics NAD+ Intravenous Therapy Introduction
7.3.4 Azivmedics Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.3.5 Azivmedics Recent Development
7.4 Reset IV
7.4.1 Reset IV Company Details
7.4.2 Reset IV Business Overview
7.4.3 Reset IV NAD+ Intravenous Therapy Introduction
7.4.4 Reset IV Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.4.5 Reset IV Recent Development
7.5 Thedripclub
7.5.1 Thedripclub Company Details
7.5.2 Thedripclub Business Overview
7.5.3 Thedripclub NAD+ Intravenous Therapy Introduction
7.5.4 Thedripclub Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.5.5 Thedripclub Recent Development
7.6 Toronto Functional Medicine Centre
7.6.1 Toronto Functional Medicine Centre Company Details
7.6.2 Toronto Functional Medicine Centre Business Overview
7.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Introduction
7.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.6.5 Toronto Functional Medicine Centre Recent Development
7.7 Mobileivmedics
7.7.1 Mobileivmedics Company Details
7.7.2 Mobileivmedics Business Overview
7.7.3 Mobileivmedics NAD+ Intravenous Therapy Introduction
7.7.4 Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.7.5 Mobileivmedics Recent Development
7.8 Rocky Mountain Ivmedics
7.8.1 Rocky Mountain Ivmedics Company Details
7.8.2 Rocky Mountain Ivmedics Business Overview
7.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Introduction
7.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.8.5 Rocky Mountain Ivmedics Recent Development
7.9 Seaside Skin Care
7.9.1 Seaside Skin Care Company Details
7.9.2 Seaside Skin Care Business Overview
7.9.3 Seaside Skin Care NAD+ Intravenous Therapy Introduction
7.9.4 Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.9.5 Seaside Skin Care Recent Development
7.10 Premiumhealth
7.10.1 Premiumhealth Company Details
7.10.2 Premiumhealth Business Overview
7.10.3 Premiumhealth NAD+ Intravenous Therapy Introduction
7.10.4 Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.10.5 Premiumhealth Recent Development
7.11 Effect Doctors
7.11.1 Effect Doctors Company Details
7.11.2 Effect Doctors Business Overview
7.11.3 Effect Doctors NAD+ Intravenous Therapy Introduction
7.11.4 Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.11.5 Effect Doctors Recent Development
7.12 Nadclinic
7.12.1 Nadclinic Company Details
7.12.2 Nadclinic Business Overview
7.12.3 Nadclinic NAD+ Intravenous Therapy Introduction
7.12.4 Nadclinic Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.12.5 Nadclinic Recent Development
7.13 Hydrate IV Bar
7.13.1 Hydrate IV Bar Company Details
7.13.2 Hydrate IV Bar Business Overview
7.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Introduction
7.13.4 Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.13.5 Hydrate IV Bar Recent Development
7.14 LIVV Natural
7.14.1 LIVV Natural Company Details
7.14.2 LIVV Natural Business Overview
7.14.3 LIVV Natural NAD+ Intravenous Therapy Introduction
7.14.4 LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.14.5 LIVV Natural Recent Development
7.15 BioReset Medical
7.15.1 BioReset Medical Company Details
7.15.2 BioReset Medical Business Overview
7.15.3 BioReset Medical NAD+ Intravenous Therapy Introduction
7.15.4 BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.15.5 BioReset Medical Recent Development
7.16 IV Boost UK
7.16.1 IV Boost UK Company Details
7.16.2 IV Boost UK Business Overview
7.16.3 IV Boost UK NAD+ Intravenous Therapy Introduction
7.16.4 IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2020-2025)
7.16.5 IV Boost UK Recent Development
8 NAD+ Intravenous Therapy Market Dynamics
8.1 NAD+ Intravenous Therapy Industry Trends
8.2 NAD+ Intravenous Therapy Market Drivers
8.3 NAD+ Intravenous Therapy Market Challenges
8.4 NAD+ Intravenous Therapy Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global NAD+ Intravenous Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global NAD+ Intravenous Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market NAD+ Intravenous Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global NAD+ Intravenous Therapy Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global NAD+ Intravenous Therapy Revenue Share by Region (2020-2025)
Table 6. Global NAD+ Intravenous Therapy Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global NAD+ Intravenous Therapy Revenue Share Forecast by Region (2026-2031)
Table 8. Global NAD+ Intravenous Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2020-2025)
Table 10. Global NAD+ Intravenous Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global NAD+ Intravenous Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2020-2025)
Table 15. Global NAD+ Intravenous Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in NAD+ Intravenous Therapy Application
Table 18. Global NAD+ Intravenous Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global NAD+ Intravenous Therapy Market Share by Players (2020-2025)
Table 20. Global Top NAD+ Intravenous Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2024)
Table 21. Ranking of Global Top NAD+ Intravenous Therapy Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by NAD+ Intravenous Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of NAD+ Intravenous Therapy, Headquarters and Area Served
Table 24. Global Key Players of NAD+ Intravenous Therapy, Product and Application
Table 25. Global Key Players of NAD+ Intravenous Therapy, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America NAD+ Intravenous Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America NAD+ Intravenous Therapy Revenue Market Share by Company (2020-2025)
Table 29. North America NAD+ Intravenous Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America NAD+ Intravenous Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe NAD+ Intravenous Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe NAD+ Intravenous Therapy Revenue Market Share by Company (2020-2025)
Table 33. Europe NAD+ Intravenous Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe NAD+ Intravenous Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific NAD+ Intravenous Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific NAD+ Intravenous Therapy Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific NAD+ Intravenous Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific NAD+ Intravenous Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America NAD+ Intravenous Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America NAD+ Intravenous Therapy Revenue Market Share by Company (2020-2025)
Table 41. Latin America NAD+ Intravenous Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America NAD+ Intravenous Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa NAD+ Intravenous Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa NAD+ Intravenous Therapy Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa NAD+ Intravenous Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa NAD+ Intravenous Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 47. The Wellness Lab Company Details
Table 48. The Wellness Lab Business Overview
Table 49. The Wellness Lab NAD+ Intravenous Therapy Product
Table 50. The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 51. The Wellness Lab Recent Development
Table 52. Conciergemdla Company Details
Table 53. Conciergemdla Business Overview
Table 54. Conciergemdla NAD+ Intravenous Therapy Product
Table 55. Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 56. Conciergemdla Recent Development
Table 57. Azivmedics Company Details
Table 58. Azivmedics Business Overview
Table 59. Azivmedics NAD+ Intravenous Therapy Product
Table 60. Azivmedics Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 61. Azivmedics Recent Development
Table 62. Reset IV Company Details
Table 63. Reset IV Business Overview
Table 64. Reset IV NAD+ Intravenous Therapy Product
Table 65. Reset IV Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 66. Reset IV Recent Development
Table 67. Thedripclub Company Details
Table 68. Thedripclub Business Overview
Table 69. Thedripclub NAD+ Intravenous Therapy Product
Table 70. Thedripclub Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 71. Thedripclub Recent Development
Table 72. Toronto Functional Medicine Centre Company Details
Table 73. Toronto Functional Medicine Centre Business Overview
Table 74. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product
Table 75. Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 76. Toronto Functional Medicine Centre Recent Development
Table 77. Mobileivmedics Company Details
Table 78. Mobileivmedics Business Overview
Table 79. Mobileivmedics NAD+ Intravenous Therapy Product
Table 80. Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 81. Mobileivmedics Recent Development
Table 82. Rocky Mountain Ivmedics Company Details
Table 83. Rocky Mountain Ivmedics Business Overview
Table 84. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product
Table 85. Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 86. Rocky Mountain Ivmedics Recent Development
Table 87. Seaside Skin Care Company Details
Table 88. Seaside Skin Care Business Overview
Table 89. Seaside Skin Care NAD+ Intravenous Therapy Product
Table 90. Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 91. Seaside Skin Care Recent Development
Table 92. Premiumhealth Company Details
Table 93. Premiumhealth Business Overview
Table 94. Premiumhealth NAD+ Intravenous Therapy Product
Table 95. Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 96. Premiumhealth Recent Development
Table 97. Effect Doctors Company Details
Table 98. Effect Doctors Business Overview
Table 99. Effect Doctors NAD+ Intravenous Therapy Product
Table 100. Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 101. Effect Doctors Recent Development
Table 102. Nadclinic Company Details
Table 103. Nadclinic Business Overview
Table 104. Nadclinic NAD+ Intravenous Therapy Product
Table 105. Nadclinic Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 106. Nadclinic Recent Development
Table 107. Hydrate IV Bar Company Details
Table 108. Hydrate IV Bar Business Overview
Table 109. Hydrate IV Bar NAD+ Intravenous Therapy Product
Table 110. Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 111. Hydrate IV Bar Recent Development
Table 112. LIVV Natural Company Details
Table 113. LIVV Natural Business Overview
Table 114. LIVV Natural NAD+ Intravenous Therapy Product
Table 115. LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 116. LIVV Natural Recent Development
Table 117. BioReset Medical Company Details
Table 118. BioReset Medical Business Overview
Table 119. BioReset Medical NAD+ Intravenous Therapy Product
Table 120. BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 121. BioReset Medical Recent Development
Table 122. IV Boost UK Company Details
Table 123. IV Boost UK Business Overview
Table 124. IV Boost UK NAD+ Intravenous Therapy Product
Table 125. IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2020-2025) & (US$ Million)
Table 126. IV Boost UK Recent Development
Table 127. NAD+ Intravenous Therapy Market Trends
Table 128. NAD+ Intravenous Therapy Market Drivers
Table 129. NAD+ Intravenous Therapy Market Challenges
Table 130. NAD+ Intravenous Therapy Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. NAD+ Intravenous Therapy Product Picture
Figure 2. Global NAD+ Intravenous Therapy Market Share by Type: 2024 VS 2031
Figure 3. NAD+ Mixed Vitamin Injections Features
Figure 4. Pure NAD+ Injection Features
Figure 5. Global NAD+ Intravenous Therapy Market Share by Application: 2024 VS 2031
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Residential
Figure 9. NAD+ Intravenous Therapy Report Years Considered
Figure 10. Global NAD+ Intravenous Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global NAD+ Intravenous Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global NAD+ Intravenous Therapy Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America NAD+ Intravenous Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe NAD+ Intravenous Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Asia-Pacific NAD+ Intravenous Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Latin America NAD+ Intravenous Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Middle East & Africa NAD+ Intravenous Therapy Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global NAD+ Intravenous Therapy Market Share by Players in 2024
Figure 19. Global Top NAD+ Intravenous Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by NAD+ Intravenous Therapy Revenue in 2024
Figure 21. North America NAD+ Intravenous Therapy Market Share by Type (2020-2025)
Figure 22. North America NAD+ Intravenous Therapy Market Share by Application (2020-2025)
Figure 23. Europe NAD+ Intravenous Therapy Market Share by Type (2020-2025)
Figure 24. Europe NAD+ Intravenous Therapy Market Share by Application (2020-2025)
Figure 25. Asia-Pacific NAD+ Intravenous Therapy Market Share by Type (2020-2025)
Figure 26. Asia-Pacific NAD+ Intravenous Therapy Market Share by Application (2020-2025)
Figure 27. Latin America NAD+ Intravenous Therapy Market Share by Type (2020-2025)
Figure 28. Latin America NAD+ Intravenous Therapy Market Share by Application (2020-2025)
Figure 29. Middle East & Africa NAD+ Intravenous Therapy Market Share by Type (2020-2025)
Figure 30. Middle East & Africa NAD+ Intravenous Therapy Market Share by Application (2020-2025)
Figure 31. The Wellness Lab Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 32. Conciergemdla Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 33. Azivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 34. Reset IV Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 35. Thedripclub Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 36. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 37. Mobileivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 38. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 39. Seaside Skin Care Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 40. Premiumhealth Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 41. Effect Doctors Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 42. Nadclinic Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 43. Hydrate IV Bar Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 44. LIVV Natural Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 45. BioReset Medical Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 46. IV Boost UK Revenue Growth Rate in NAD+ Intravenous Therapy Business (2020-2025)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Related Reports
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published Date: 2024-11-11
Pages: 154
USD 4900.00
(Single User License)
Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published Date: 2024-11-11
Pages: 131
USD 4350.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published Date: 2024-11-11
Pages: 100
USD 2900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 125
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 117
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 105
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 133
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published: 2024-11-11
Pages: 154
USD 4900.00 (Single User License)Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published: 2024-11-11
Pages: 131
USD 4350.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published: 2024-11-11
Pages: 100
USD 2900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-03-13
Pages: 97
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 125
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 117
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 105
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 133
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research